Gilteritinib Fumarate - Request Quote
Gilteritinib Fumarate
| SZ CAT No: | SZ-G023001 |
| CAS No | NA |
| Mol.F. | C29H44N8O3 : C4H4O4 |
| Mol.Wt. | 552.7 : 116.1 |
| Inv. Status | In Stock |
| Rel. CAS No | 1254053-43-4 (free base) ; 1254053-84-3 (Hemifumarate salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Gilteritinib Fumarate is chemically 6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide fumarate. Gilteritinib Fumarate is supplied with detailed characterization data compliant with regulatory guideline. Gilteritinib Fumarate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gilteritinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Gilteritinib Fumarate
Purchase Gilteritinib Fumarate
Gilteritinib Fumarate suppliers
Gilteritinib Fumarate manufacturers
Gilteritinib Fumarate price
Order Gilteritinib Fumarate
Enquire Gilteritinib Fumarate
Gilteritinib Fumarate cost
Gilteritinib Fumarate Supplier
Gilteritinib Fumarate Distributor
Gilteritinib Fumarate for Method Validation
Gilteritinib Reference Standard
Gilteritinib Fumarate for ANDA Filing
Gilteritinib Fumarate for Forced Degradation Studies
Gilteritinib Fumarate Identification Standards
Gilteritinib Fumarate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.